Company
PocNAT is a point-of-care nucleic acid testing technology company, founded in June 2022 by a joint research team from The Hong Kong Polytechnic University and a veteran entrepreneur from MedTech Industries. It provides low-cost, rapid, and accurate solutions to the current huge demand for decentralised or point-of-care/on-site nucleic acid testing.
Description
PocNAT is a nucleic acid-based diagnostic technologies provider. It aims to develop innovative technologies and products through multidisciplinary collaboration and to serve the community for better public health protection.
Technology
PocNAT's unique gold nanoparticle-based loop-mediated isothermal amplification (Gold-LAMP) testing system is accurate, simple, low-cost, and rapid. Gold-LAMP has achieved important advancement over existing LAMP result readout methods in terms of accuracy and/or simplicity, thus holding great potential to be a next-generation gold standard in decentralised nucleic acid testing.
